Bressi Jerome Charles
SEC CIK 2034505 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | See Remarks | 335.2K | — | $9,269 | 2 | 2025-01-10 | 2025-01-15 |
Most active insiders at FATE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Valamehr Bahram | Pres, CEO, Dir | — | $168.1K |
| 2 | TAHL CINDY | See Remarks | — | $154.7K |
| 3 | Adawi Kamal | CFO | — | — |
| 4 | Redmile Group, LLC | Dir, 10% | — | — |
| 5 | EPSTEIN ROBERT S | Dir | — | — |
| 6 | RASTETTER WILLIAM H | Dir | — | — |
Bressi Jerome Charles made no open-market trades at FATE in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-16 | 2025-01-15 | FATE | FATE THERAPEUTICS INC | Bressi Jerome Charles | See Remarks | A - Grant | $0.00 | +65.0K | 335.2K | +24% | $0 |
| 2025-01-13 | 2025-01-10 | FATE | FATE THERAPEUTICS INC | Bressi Jerome Charles | See Remarks | S - Sale | $1.55 | -5,980 | 270.2K | -2% | -$9,269 |
Purchase Sale Sale after option exercise All abbreviations